FDA Encourages Lower Doses in Cancer Drug Testing

In response to patient and doctor concerns, the FDA urges more tolerable cancer treatments through Project Optimus.

Patients and doctors advocate for lower drug doses to reduce side effects without compromising effectiveness.
Project Optimus aims to include more patients in early trials to find the lowest effective doses of cancer drugs.
Advances in cancer treatment have led to longer survival, but not without challenging side effects.
The traditional 'maximum tolerated dose' approach is being questioned for newer, more targeted cancer drugs.
Ongoing studies and patient advocacy highlight the need for balance between treatment efficacy and quality of life.